---
layout: post
title: "联环药业：米力农注射液获得药品注册证书"
date: 2022-05-30 17:07:45 +0800
categories: zhengquanshibao
tags: 证券时报新闻
---
<p style="display:none;height:1px;overflow:hidden;"><br /></p><!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/unify/r/1.600513" data-code="600513|1|1" data-code2="600513|1|2|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=1.600513&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 600513_0" data-code="K 600513|1|1" data-code2="K 600513|1|2|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></a></p><!-- EM_StockImg_End --><p>联环药业(600513)5月30日晚间公告，公司米力农注射液获得药品注册证书。米力农注射液是一种磷酸二酯酶抑制剂，适用于急性失代偿性心力衰竭患者的短期静脉治疗。<br /></p><p class="em_media">（文章来源：证券时报）</p>

<http://finews.zning.xyz/html_News/NewsShare.html?infoCode=NW202205302396471725>

[返回证券时报新闻](//finews.withounder.com/category/zhengquanshibao.html)｜[返回首页](//finews.withounder.com/)